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ABSTRACT 
 
The Polytrauma/TBI Rehabilitation Center (PRC) of the Veterans 
Affairs Hospital (VAH) treats patients with Traumatic Brain Injury 
(TBI). These patients have major motor and cognitive disabilities. Most 
of the patients stay in the hospital for many months without major 
improvements. This suggests that patients, family and the VAH could 
benefit if healthcare provider had a way to better assess or “predict” 
patients’ progression. The individual progress of patients over time is 
assessed using a pre-defined multi-component performance measure 
Functional Independence Measures (FIM) at admission and discharge, 
and a semi-quantitative documentation parameter Clinical Pathway 
(CP) at weekly intervals. This work uses already de-identified and 
transformed data to explore developing a clinical outcome predictive 
model for patients with TBI, as early as possible. The clinical outcome 
is measured as percentage of recovery using CP scores. The results of 
this research will allow healthcare providers to improve the current 
resource management (e.g. staff, equipment, space) through setting 
goals for each patient, as well as to provide the family more accurate 
and timely information about the status and needs of the patient. 
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CHAPTER I:  
INTRODUCTION 
 
The James A. Haley Veterans Affairs Hospital (JAHVAH) receives 
soldiers from the Operation Enduring Freedom (OEF) in Afghanistan 
and in the Operation Iraqi Freedom (OIF) in Iraq. They present 
Traumatic Brain Injuries (TBI) caused by exposure to explosion on the 
field of combat. Veterans Affairs Hospital (VAH) operates a designated 
Polytrauma Rehabilitation Center (PRC) caring for wounded 
servicemen with complex injuries. Patients are admitted at distinct 
functional levels and have variable degrees of recovery. Many require 
total care, which includes comprehensive rehabilitative therapies over 
multiple stages, leading to high utilization of resources.  
This work main objective is to explore the development of a 
predictive model to forecast the patient’s clinical outcome as early as 
possible. The effort is deemed necessary due to the following: a) the 
complexity of rehabilitating these patients: b) the families’ need of 
accurate information and proper preparation for the discharge/transfer 
event; and c) the hospital’s need of an effective and efficient utilization 
of resources. 
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The model is based on one of the functional metric utilized in the 
PRC to measure motor and cognitive disabilities: “Clinical Pathway” 
(CP). This metric is comprised by 18 different components, each one 
measured in a scale from 1 to 7.  
The two models propose in this work use as output variable a 
percentage of potential recovery, which is a transformation of the 
regularly used delta score, i.e. the difference between discharge score 
and admission score. It is hypothesize that the use of this new variable 
will improve the accuracy of the prediction and be more meaningful 
than the “regularly variable delta”.  
The limitation of this work, however, lies in the sample size, 
which is49 patients. This amount of patients does not allow validating 
the metric “Clinical Pathway” as a tool to measure clinical outcomes, 
nor allows having training and testing sets.  
An effective predictive model should help in: deciding when to 
discharge transfer patients, a better utilize staff and equipment, 
provide more accurate and early information to the families about the 
rehabilitative status of the patients, and a better prepare the families 
for the discharge or transfer instance. 
This work is divided in four chapters. Chapter II explains the 
context and foundations that have motivated to develop this study. 
Chapter III explains the methodology used to achieve the objective 
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stated before, basically this work is based on applying the initial four 
data mining steps: data extraction, data cleaning, data transformation, 
and model building. Chapter IV analyzes the proposed models 
considering the contributions and limitations of each one. Finally, 
Chapter V summarizes the main conclusions of this research and lays 
out possible future work.  
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CHAPTER II: 
CONTEXT 
 
Chapter II is divided into three sections. The first section 
addresses TBI and its relationship with the “Wounded Warriors” that 
come from the OEF and the OIF. The second section explains the 
relationship between the TBI and the Polytrauma/TBI System of Care 
(PSC) of the VAH. The third section shows the impacts and needs of 
the families in the rehabilitation process of the patients with TBI.  
 
Traumatic Brain Injury  
On December 31st 2011, 152,000 active military personnel were 
deployed in the OEF in Afghanistan and in the OIF in Iraq, as 
consequence of the Global War on Terror (GWOT) (Belasco, 2009; 
Department of Defense, 2012). In the OEF, 18,191 soldiers were 
wounded between October 2001 and December 2012 (Department of 
Defense, 2013a), and in the OIF, 31,926 soldiers were wounded 
between March 2003 and December 2012 (Department of Defense, 
2013b).  
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Blast injury has been the main war wound in action in the GWOT 
(Mernoff & Correia, 2010; Owens et al., 2008; Sayer et al., 2008). 
This is a damage caused by a “violent explosion” or by the “wave of 
pressure from such an explosion” (Department of Veterans Affairs, 
2011b). The most substantial sources that produce this wound are 
rocket-propelled grenades (RPGs), improvised explosive devices 
(IEDs), explosively formed projectiles (EFP), mines, and booby traps 
(Belanger, Uomoto, & Vanderploeg, 2009; Veterans Health Initiative, 
2010). Technological advances in equipment have allowed that more 
soldiers survive to blast injuries than in previous conflicts (Gawande, 
2004; Mernoff & Correia, 2010; Peake, 2005; Sayer et al., 2008). 
Among blast injuries occurred in GWOT, 60% result in Traumatic Brain 
Injury (TBI) (Gawande, 2004; Ling, Bandak, Armonda, Grant, & 
Ecklund, 2009; Okie, 2005; DL Warden et al., 2005). 
According to the (Department of Veterans Affairs, 2011b), TBI is 
defined as “[…] the result of a severe or moderate force to the head, 
where physical portions of the brain are damaged and functioning is 
impaired […]”. The severity of the TBI depends on the brain region 
that was impacted, the nature and the strength of the force, and the 
physical and genetic characteristics of the victim (Kimberly Meyer, 
Kathy Helmick, Selina Doncevic, & Rachel Park, 2011). It can vary 
from mild (brief change in consciousness) to severe (long period of 
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unconsciousness). The most frequent diagnosis is mild TBI (mTBI) 
(Belanger et al., 2009). Only an 8% of the OEF and OIF veterans are 
diagnosed with severe TBI (Kimberly Meyer et al., 2011).  
The symptoms after a head injury are called Post-Concussion 
Syndrome (PCS), and depending on the severity of the injury, they 
can persist for months or years (Department of Veterans Aﬀairs & 
Department of Defense, 2010). In the case of moderate or severe TBI, 
they can even be considered as permanent sequelae (Veterans Health 
Initiative, 2010). These symptoms are physical (e.g. headaches, 
dizziness, vision changes), cognitive (e.g. concentration problems, 
memory problems, abstract thinking problems), and emotional (e.g. 
irritability, anxiety, aggression) (Veterans Health Initiative, 2010). The 
previous conditions can make the diagnosis difficult because many of 
the patients may not show visible signals of injury (Mental Illness 
Research Education and Clinical Centers, 2009). 
The majority of the patients who are screened as positive for TBI 
are also diagnosed with a mental problem; the most frequent mental 
problem is Post-Traumatic Stress Disorder (PTSD) (Taylor et al., 
2012). In turn, patients with moderate to severe TBI increase the risk 
of Post-Traumatic Epilepsy (PTE) (Masel & DeWitt, 2010), which can be 
showed up in a range of years from the moment that the head injury 
occurs (Aarabi, Taghipour, Haghnegahdar, Farokhi, & Mobley, 2000). 
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The prevalence of soldiers with TBI has labeled this injury is 
considered as the “signature wound” of this war (Okie, 2006; D. 
Warden, 2006). Likewise, the VA, which is defined as “[…] the most 
comprehensive system of assistance for veterans in the world […]” 
(Department of Veterans Aﬀairs, 2012a) has taken into account TBI as 
a priority in healthcare service (Belanger et al., 2009; Veterans Health 
Initiative, 2010).  
 
Polytrauma/TBI System of Care 
In 2005, the VA created a specialized care system for individuals 
with TBI and multiple injuries or polytrauma, which is known as 
Polytrauma/TBI System of Care (PSC) (Sigford, 2008). The mission of 
the PSC is: “[…] provides comprehensive, high-quality, and inter-
disciplinary care to patients. Teams of physicians from every relevant 
field plan and administer an individually tailored rehabilitation plan to 
help the patient recover as much as possible […]” (Department of 
Veterans Aﬀairs, 2012c).  
Even though VA provides health care services for veterans, 
collaborative agreements with the Department of Defense (DoD) have 
allowed that active duty Service Members (SMs) also can receive care 
in PSC (Uomoto, 2012; Veterans Health Initiative, 2010). From 
October 2001 until the fiscal year (FY) 2012, 804,704 SMs that left 
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active duty in OEF and OIF (including Operation New Dawn (OND)) 
have obtained care in the VA Health Care System, of which 7% have 
been inpatients (Department of Veterans Affairs, 2012). Between the 
FY 2003 and FY 2011, PSC received 2,160 inpatients with TBI (Cifu, 
2012), thus, it is estimated that over 2,600 patients with TBI have 
been treated in the PSC from the beginning of the GWOT. 
PSC is composed of four modules of care: 5 PRCs which are 
located in Richmond, VA, Tampa, FL, Minneapolis, MN, Palo Alto, CA, 
and San Antonio, TX; 23 Polytrauma Network Sites (PNS); 87 
Polytrauma Support Clinic Teams (PSCT); and 38 Polytrauma Point of 
Contact (PPOC) (Department of Veterans Aﬀairs, 2012d).  
The OEF and OIF militaries who enter the VA health care system 
may receive an initial TBI screen (Mernoff & Correia, 2010; Uomoto, 
2012; Veterans Health Initiative, 2010). The screen consists of 
determining any injury in the brain that “has made an effect in the 
consciousness” through a 5 minutes survey with questions related to 
the “current health” and “combat experiences”, as first step 
(Department of Veterans Aﬀairs, 2012b; Veterans Health Initiative, 
2010). The diagnosis is ratified using severity ratings (such as Glasgow 
Coma Scale (GCS)), computed tomography (CT) and magnetic 
resonance imaging (MRI), if the patient’s condition allows (Veterans 
Health Initiative, 2010).  
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The patients diagnosed with TBI are referred to an adequate unit 
of care depending on the severity of the damage. All of those that 
return with a deeper level of unconsciousness or in coma are sent to 
acute rehabilitation programs such as Emerging Consciousness 
Program or Brain Injury Rehabilitation in one of the five PRCs 
(Department of Veterans Affairs, 2011a; Uomoto, 2012). In these 
programs, patients may emerge from the coma and then they start 
the rehabilitation process.  
The rehabilitation process consists of cognitive, physical and 
emotional treatments such as: improving the communication skills, 
dealing with changes in behavior, treatment for dizziness and pain, 
and supporting in adjustment and coping (Department of Veterans 
Affairs, 2011a). In this stage of recovery, two Activities of Daily Living 
(ADL) assessment tools play an important role in the PSCs: Functional 
Independence Measure (FIM) and Clinical Pathway (CP) scores, which 
evaluate the progress of patients in terms of cognitive and motor 
functions.  
FIM measures the functions of the patients routinely at 
admission and at discharge from the rehabilitation unit, and consists of 
18 components: 13 of them measure motor tasks, and the 5 
remainder, measure cognitive tasks (Uniform Data System for Medical 
Rehabilitation, 2013). CP measures similar functions weekly and also 
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comprises 18 components: 11 refer to motor functions and 7 to 
cognitive functions (Table 1).  
 
Table 1 Motor and cognitive FIM and CP components 
Functional Independence Measure 
FIM 
Clinical Pathway 
CP 
Motor 
Eating 
Grooming 
Bathing/showering 
Dressing upper body 
Dressing lower body 
Toileting 
Bladder management 
Bowel management 
Transfers:  bed/chair/wheelchair 
Transfer s: Toilet 
Transfers: bathtub/shower 
Locomotion: walk/wheelchair 
Locomotion: stairs 
Cognitive 
Comprehension 
Expression 
Social interaction 
Problem solving 
Memory 
Motor 
Eating 
Grooming 
Bathing 
Dressing - Upper Body 
Dressing - Lower Body 
Toileting 
Bladder Management 
Bowel Management 
Bed Mobility 
Locomotion 
Transfer 
Cognitive 
Language Comprehension 
Expression 
Attention 
Memory 
Social Language 
Problem Solving 
Safety 
Source: VA Hospital Data Set 
 
 
FIM score has been used to measure the progress of 
rehabilitation in a number of different condition such as: stroke, spinal 
cord injury, brain injury, multiple sclerosis, orthopedic conditions, and 
geriatrics (Uniform Data System for Medical Rehabilitation, 2013). It 
has been the most widely used assessment tool used to measure 
clinical outcomes in the United States (Cournan, 2011).  
(Black, 2012) states measuring the clinical outcome can help in: 
providing feedback to the team to improve the services/programs and 
11 
 
to monitor the resources utilization; facilitating the communication 
among the stakeholders (clinicians, family members, patients), 
through a “meaningful” and “readily available” information flow; 
establishing individual goals for each patient; and assisting in decision-
making about the discharge time.  
Similarly, (Poon, Zhu, Ng, & Wong, 2005) established that 
predicting clinical outcomes of patients with TBI has a positive effect in 
the “priority-setting of the limited resources”, as well as, an impact in 
the family members since it provides “essential information for 
counseling of the family”. This last effect is very important due to the 
leading role of the family in the rehabilitation process, and at 
discharge, since the usual discharge destination is “home” with 67% of 
the patients treated in the PRCs VAH (Cifu, 2012).  
 
Impacts on and Needs of the Family System 
A war has great consequences life of a family and many studies 
refer to the effects caused by the war on family members (Kelley & 
Jouriles, 2011; Lester et al., 2010; Paris, DeVoe, Ross, & Acker, 
2010). The characteristics of the service member's family before the 
injury, named as pre-TBI, are important in determining the way that 
the family members will deal with the “psychological adjustment” and 
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the “quality of life” once the injured soldier returns (Dausch & Saliman, 
2009; McFarlane, 2009). 
Relocation and employment problems, changes in the family 
roles, concern for the deployed family member, economic problems, 
and family conflicts are some of the pre-TBI problems that the families 
of the SMs have to face (Makin-Byrd, Gifford, McCutcheon, & Glynn, 
2011; McFarlane, 2009).  (Mansfield et al., 2010) concluded that the 
length of deployment in Iraq and Afghanistan has a mental health 
effect on the wives of the SMs: depressive disorder, anxiety, and acute 
stress reaction or adjustment disorder are the most common 
diagnoses. In addition, the previous causes can contribute to an 
increase in the rate of maltreatment (e.g. neglect, physical abuse, 
emotional abuse, and sexual abuse) in children of the families with 
active duty SMs (Gibbs, Martin, Kupper, & Johnson, 2007).  
On the other hand, the different family reactions post-TBI 
associated with the stage of rehabilitation of the patients were 
established by (Lezak, 1986) and adapted by VA (Veterans Health 
Initiative, 2010), which range from depression, shock, and denial, to 
complete reorganization of the family. The work of (Verhaeghe, 
Defloor, & Grypdonck, 2005) states that spouses have a greater 
psychological impact than parents in caring for individuals that have 
13 
 
TBI and, at the same time, the negative effects on the caregivers 
increase when there are children living at home.  
To reduce the negative psychological consequences for the 
family during the rehabilitation process, (Bond, Draeger, Mandleco, & 
Donnelly, 2003) established four needs of the families of the patients 
with TBI: “need for involvement” (contribution of the family in the care 
of patient), “need for consistent information” (the condition of the 
patient must be reported to the family beyond doubts or contradictions 
by health care personnel), “need to make sense of the experience” 
(understandable and comprehensive information about the procedures 
performed to the patient), and “need to know” (family members prefer 
to know the truth about the patient's condition whatever the outcome 
may be). This last need is directly related to the clinical outcome.  
On the other hand, an early study (Mintz, Van Horn, & Levine, 
1995) stated that family welfare indices improve when treatment is 
given in an outpatient program, as opposed to when the care is 
provided in the center of rehabilitation. In turn, the necessities of 
both, the patient and the family are different when the patient stays in 
the hospital as inpatient, from those required when patients receive 
outside assistance (Griffin, Friedemann-Sánchez, Hall, Phelan, & van 
Ryn, 2009). The information and the support that the caregivers can 
receive at discharge is important since they not only deal with helping 
14 
 
the family members in ADLs, but also with appointments, devices, and 
management of emotions and pain (Griffin et al., 2012).  
Based on the benefits for both healthcare providers and the 
families, to estimate in advance the possible clinical outcomes in 
patients with TBI, this work shows an approach to predict the potential 
recovery using the CP scores. The use of CP for this analysis provides 
a new metric, using serial, weekly measure which has not previously 
been published. 
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CHAPTER III: 
METHODOLOGY 
 
This chapter describes the methodology used to achieve the 
objective of predicting clinical outcome in patients with TBI using 
clinical pathway score. The work is based on the five steps depicted in 
the Figure 1. This chapter has been divided in the four first stages of 
the data mining process: data extraction, data cleaning, data 
transformation, and data mining or model building. 
 
 
Source: Own creation 
Figure 1 Data mining steps 
 
Data Extraction 
The data used in this study corresponds to a dataset of 49 
patients, which was extracted from the VA electronic medical records. 
Important note, the data was appropriately pre-processed by 
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authorized people before being analyzed in this work, to de-identify 
the patients, with conversion of dates to hospital day number. This 
action generated the following two “sub-datasets”: 
Sub-dataset 1: False patient ID, FIM scores per component at 
admission and at discharge (Table 2). 
 
Table 2 Example of data collection for FIM score 
Component 
False Patient ID 
1 2 3 4 5 6 
Eating 1 1 2 2 2 … 
Grooming 1 1 2 2 … … 
Bathing 1 1 1 … … … 
Dressing – U 1 1 … … … … 
… 2 … … … … … 
 
Sub-dataset 2: False patient ID, weekly score of the 18 CP 
components. Measurement numbering begins with 0 (Table 3).  
 
Table 3 Example of data collection for CP score (record of one patient) 
 
False 
ID 
Measurement Eating Grooming Bathing 
Dressing - 
Upper Body 
 
1 0 3 2 4 3 … 
 1 3 2 4 2 … 
 2 3 2 4 … … 
 3 3 2 … … … 
 4 2 … … … … 
 5 … … … … … 
17 
 
Data Cleaning  
Cleaning sub-dataset 2 basically consists of dealing with CP 
missing values including missing rows related to US federal holidays. 
The data set has a total of 72 missing rows and, additionally, around 
100 missing values. 
Missing values can be classified in four categories: (1) first 
measurement (or measurement 0) with missing values/row, (2) 
missing values/rows in the middle, (3) last measurement with missing 
values/row, and (4) a segment of missing values (i.e. more than two 
consecutive missing values in a column). 
The criteria used to fill the missing values are explained below: 
 
First Measurement with Missing Values/Row 
To deal with missing values in the first row the cross-
multiplication technique is used considering the tendency shown by the 
patient in the scores of the other components, from the first to the 
second measurement. Table 4 shows an example. 
 
Table 4 Example of a missing value in the first row 
ID Measurement Eating Grooming Bathing … Safety 
1 0  ?    
 1      
 2    … … 
 3   … … … 
18 
 
The missing value of the “Grooming” in the first row, is 
calculated by the ratio between the summation of the squares (first 
row) and the summation of the triangles (second row), the result is 
multiplied by the circle.  
On the other hand, if there is a missing row in the measurement 
0 and all the values in the measurement 1 are equal to 7 (Table 5), 
the missing row is replaced by the score 7. Otherwise, the row is 
deleted and all the measurements are moved one week up, i.e. 
measurement 1 becomes measurement 0, due to the uncertainty of 
the extrapolation process in a complete row and the importance of the 
admission scores for the prediction model.  
 
Table 5 Example of a missing row in the first row 
 
 
 
 
 
 
 
Middle Missing Values/Rows 
The criterion for replacing a missing value in the middle is the 
same as a middle missing row. If the empty cell falls between two 
different numbers that are two units apart (e.g. 4 and 2) it is replaced 
by the mean (e.g. 3). If the mean is a decimal value, i.e. the missing 
number falls between two different values that are consecutive (e.g. 4 
ID Measurement CP1 CP2 CP3 … CP18 
1 0 ? ? ? … ? 
 1 7 7 7 … 7 
 2    … … 
 3   … … … 
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and 3), the number is rounded to the nearest integer (e.g. 3.5 ≈ 4). If 
there are more than a two unit distance (e.g. 7 and 2 or 6 and 2) the 
two previous criteria are used depending on if the mean is decimal or 
integer, respectively. The use of the mean is based on the assumption 
of progressive in the recovery. 
 
Last Measurement Missing Value/Row 
A missing row in the last measurement is deleted and the prior is 
considered the last record as the discharge measurement. A missing 
value in the last row is replaced using cross-multiplication, as in the 
example described in Table 4.  
 
Segment of Missing Values 
If there are two or more consecutive missing values in a column 
in the middle of the dataset, all the missing values are replaced by the 
previous measurement, assuming that the patient has kept the same 
condition during that time. Cross-multiplication is used if the patient 
does not have data in a specific segment, which includes a missing 
value in the admission row or in the discharge row.  
On the other hand, since the FIM scores do not present missing 
values no replacement rule has been used.  
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Data Transformation 
In this section the transformation of the data to create the input 
and the output variable for setting the model is explained. In the first 
section the response variable and, in the second section the selection 
of the explanatory variables is explained. 
 
Response Variables 
The response variables should measure the clinical outcome. 
Based on the purpose of the clinical outcome presented before, the 
variable should measure the progress achieved during the inpatient 
rehabilitation. The data collection related to the FIM and the CP scores 
is used to create a continuous variable in terms of the improvements 
in the motor and cognitive skills of the patients.  
FIM and CP are metrics that represent the level of independence 
of the patient. Table 6 and Appendix B show the scoring criteria for 
FIM and CP, respectively. The metrics are rated from 1 to 7 and they 
are considered as ordinal Likert-scales (Nanna & Sawilowsky, 1998) 
because it is uncertain if the values are equally spaced. 
Although some literature suggests that the use of parametric 
methods in Likert-type scales accomplishes acceptable conclusions 
(Norman, 2010), in this work the individual components will be 
analyzed as ordinal scales. However, the sum of the scores for FIM and 
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CP metrics will be considered as interval scale, as it was suggested by 
(Kidd et al., 1995) in an early study developed for the FIM scores.  
 
Table 6 FIM scoring criteria 
 
Score Description 
1 Total assistance (patient can perform less than 25% of the 
task or requires more than one person to assist 
2 Maximal assistance (patient can perform 25% to 49% of 
tasks) 
3 Moderate assistance (patient can perform 50% to 74% of 
task) 
4 Minimal contact assistance (patient can perform 75% or 
more of task)  
5 Supervision or Setup 
6 Modified independence (patient requires use of a device, but 
no physical assistance) 
7 Complete independence 
Source: (Uniform Data System for Medical Rehabilitation, 2013) 
 
Based on the previous statement, the total “FIM 
Admission/Discharge” and the total “CP Admission/Discharge” is the 
result of dealing with all the components in each metric, as a group.  
Consequently, the total “FIM Admission” is calculated based on the 
score when the patient is admitted, and total “FIM Discharge” is 
computed by considering the last score registered as an inpatient. In 
the FIM scale, 1 indicates total dependence of the patient, and 7 
means complete independence, thus, the possible total FIM score 
ranges from 18 to 126, where a higher score implies more 
independence of the patients. 
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The same analysis can be performed for CP, in which it is also 
possible to calculate the total weekly progress achieved by the patient 
between admission and discharge. The meaning of the CP scale is 
opposite to the FIM scale: 1 indicates that the patient is totally 
independent and 7 means the patient is completely dependent. In 
turn, the possible total CP score can vary from 126 to 18with 126 
indicating complete dependence in the motor and cognitive functions. 
Table 7 displays the descriptive statistics of the total “FIM 
Admission/Discharge” and total “CP Admission/Discharge” of the 
sample.  
 
Table 7 Descriptive statistics of FIM and CP at admission and discharge 
  
FIM 
Admission  
FIM 
Discharge  
CP 
Admission  
CP 
Discharge  
Mean 52.65 88.22 84.20 56.04 
Median 46 108 95 37 
Mode 18 18 126 126 
Trimmed Mean (10%) 50.28 92.62 85.74 51.62 
Standard Deviation 31.61 39.61 36.20 40.05 
Minimum 18 18 23 18 
Maximum 122 126 126 126 
* The range for FIM score is [18, 126], and the range for CP score [126, 18]. 
 
The difference between the “FIM/CP Discharge” and the “FIM/CP 
Admission” is called “gain”, “delta”, or “maximum improvement 
achieved”. It refers to the progress in motor and cognitive skills 
accomplished by the patient during the rehabilitation time. Many 
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studies utilize the “delta” as the outcome in predicting/analyzing 
functional improvement (Ng, Stein, Ning, & Black-Schaffer, 2007; 
Poon et al., 2005; Ring, Feder, Schwartz, & Samuels, 1997; Sayer et 
al., 2008). 
In this study we propose the use of a new variable, “delta 
transformed”, as outcome variable. In this variable, the delta between 
discharge and admission achieved during the length of stay in the 
hospital are converted to a proportion based on the maximum delta 
possible at the time of admission, resulting in two possible response 
variables: Delta FIM Transformed or DFT (Eq. 1), and Delta CP 
Transformed or DPT (Eq. 2). DFT and DPT are computed by dividing 
the delta (or “maximum improvement achieved”) by the maximum 
potential recovery of the specific patient at the time of admission. 
These variables indicate what percentage of the total possible recovery 
of the patient is accomplished at the end of the rehabilitation. 
 
 DFT = 
FIM Discharge - FIM Admission
126 - FIM Admission
 Equation 1 
   
 DPT  = 
 CP Discharge  - CP Admission  
18 - CP Admission
 
Equation 2 
 
 
The use of the DFT or DPT allows equaling two patients who 
have different initial conditions and different deltas, at the end of 
rehabilitation. The base on this postulate lies on the conclusion 
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established by (Sayer et al., 2008) for this type of patients: at low 
levels of motor and cognitive functions the patients “make 
considerable progress over the course of the hospitalization” and, 
conversely, at high levels of functioning the patients “do not exhibit 
much functional gain over the course of the treatment”.  
Figure 2 depicts an example where two patients have the same 
percentage of recovery (DPT) at discharge time, the admission score is 
different and the delta of patient 2 is higher than the delta of patient 
1.  
 
 
Source: Own creation 
Figure 2 Example of two patients with similar percentage of recovery (DPT) at 
the end of the rehabilitation 
 
On the other hand, note that the Eq. 1 is defined as long as FIM 
Admission is different from 126, and the Eq. 2 is defined if CP 
Admission is different than 18. Insofar as the FIM/CP Admission scores 
are equal to the maximum scores possible indicates that the patient is 
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completely independent and consecutively, he/she does not require 
care in the PRC.  
DFT and DPT can take values equal to or close to 0, which 
means that the patient’s state is the same (no or minimal recovery). 
In the same way, DFT or DPT close to 1 means that the patient 
showed significant progress relative to his/her potential. In turn, 
according to the Eq. 1 and 2, DFT and DPT can also be negative values 
i.e. the patient can worsen during rehabilitation. Even though this 
latter case is not expected, it is possible. A negative DFT or DPT may 
be the result of factors independent of the treatment. Nevertheless, 
the expected result is that the clinical outcome of the patient shows a 
recovery or at least the patient keeps his/her initial motor and 
cognitive conditions, i.e. DFT and DPT are constrained to a range 
between 0 and 1.  
The summary statistics of the DFT and DPT of the sample are 
shown in Table 8; both variables are skewed to the left, and their 
means are less than the medians. The trimmed means for DFT and 
DPT are very close to the untrimmed means, indicating the absence of 
instance(s) far from the rest of the data. The standard deviation is 
similar between DFT and DPT.  
The sample shows values between 0 and 1 for DFT. On the other 
hand, the values of the sample for DPT, are ranged between -0.02 and 
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1 (the negative value corresponds to a single patient). It is possible to 
keep the patient’s record or to consider the value as an outlier, and 
then, delete the patient. In this case, since the value corresponds to a 
single instance and it is close to 0, it is not expected that it 
significantly affects the model, thus, the first option is used.  
 
Table 8 Descriptive statistics of DFT and DPT 
Descriptive Statistic DFT DPT 
Mean 0.57 0.52 
Median 0.65 0.62 
Mode 0 0 
Trimmed Mean (10%) 0.59 0.54 
Standard Deviation 0.35 0.34 
Minimum 0 -0.02 
Maximum 1 1 
 
On the other hand, the values obtained for DFT and DPT seem to 
be associated according to the scatterplot in Figure 3. The Pearson’s 
Correlation Coefficient r between DFT and DPT is 0.93, with a p-value 
<0.001, which suggests that the correlation is statistically significant. 
The association between these two variables indicates the use of 
either of them as response variable for the prospective model. The CP 
seems to be the best choice, since it is a weekly metric for the entire 
segment of care and provides more evidence about the progress of the 
patients in comparison to the FIM score, which is only at admission 
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and discharge. To be consistent with the metric selected, "DPT" is used 
as the response variable.  
 
 
Figure 3 Relationship between DFT and DPT 
 
Explanatory Variables 
Since CP is a metric with weekly measurements, each week is a 
potential explanatory variable for the predictive model. To create 
appropriate input variables it is assumed that the motor and cognitive 
disabilities of the patient are evaluated n + 1 times, where n is the 
amount of weeks of treatment. This means that once the patient is 
admitted into the PRC the staff initially measures the 18 components, 
and based on the results they schedule the first week of treatment. 
After the first week, the 18 components are evaluated again to 
schedule the treatment of the subsequent week, and so on (Figure 4). 
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n: length of stay in the PRC in weeks 
Source: Own creation 
Figure 4 Measurement and length of stay 
 
The selection of number of weeks being analyzed as early 
predictors is based on the number of inpatients per week, and then, 
the correlation of the input variables with the response variable, DPT. 
Figure 5 shows the percentage of patients by duration of inpatient 
segment of care. The curve decreases as weeks accrue and the 
patients are discharged.  
 
 
 
Figure 5 Percentage of patients by duration of inpatient segment of care, 122 
weeks (left) and 6 first weeks (right) 
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Figure 5 shows that over 80% of the inpatients stay in the 
hospital for 6 weeks. The percentage of inpatients falls to 78% in week 
7 and 69% in week 8. The sample has a mean of length of stay of 21 
weeks, with a minimum of 3 weeks, and a maximum of 122 weeks. 
Each of these 6 first weeks will be considered in the analysis of 
explanatory variables. The 6 weeks is involving 7 measurements: 
admission score (or measurement 0), and the measurement from 
week 1 to 6. 
The correlation between Total Motor Measurement m or TMMm   
(sum of the 11 motor CP components), and Total Cognitive 
Measurement m or TCMm (sum of the 7 cognitive CP components), 
showS a strong positive linear association in the 7 measurements with 
a p-value <0.001 according to the Pearson Correlation Coefficient r in 
Table 9 and the scatterplots in Figure 6. 
 
Table 9 Pearson Correlation Coefficient between TMMm and TCMm 
 
TMM0 TMM1 TMM2 TMM3 TMM4 TMM5 TMM6 
TCM0 0.860       
TCM1  
0.861      
TCM2  
 0.891     
TCM3  
  0.907    
TCM4  
   0.906   
TCM5  
    0.890  
TCM6  
     0.884 
P-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
TMMm = Total Motor Measurement m 
TCMm = Total Cognitive Measurement m 
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Source: Own creation 
Figure 6 Scatterplots of the TMMm and TCMm 
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We conclude from the previous exploration of the 7 
measurements that it is possible to use the summation of the 18 
components as a single input variable each week instead of using the 
TMMm and TCMm as two different weekly potential inputs to the model. 
Note that since motor and cognitive functions are pre-defined groups, 
it is implied that the components that shape both groups are related to 
each other.  
The input variables considered in the analysis are two different 
types: the “CP Admission” (Eq. 3) and the “Delta Pathway Transformed 
Measurement m (DPTMm)”, where m is the week number of the 
measurement (Eq. 4).  
 
 CP Admission=  (CP components 1 week)i
18
i=1
 Equation 3 
   
 DPTMm = 
CP Measurement m - CP Admission
18 - CP Admission
 
Equation 4 
 
 
CP Admission corresponds to the summation of the 18 
components once the patient is admitted in the PRC and represents 
the motor and cognitive skills of the patient in a specific instance since 
it is not compared with any previous time. The domain of the variable 
is between 18 and 126.  
On the other hand, the DPTMm is a variable that takes into 
consideration the treatment received for the patient previous to the 
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mth measurement. It evaluates the progress of the patient in 
percentage of recovery achieved every week using as reference the CP 
Admission. The variable DPTMm is based on the same foundations of 
the DPT, explained previously. The domain of DPTMm is between -1 
and 1, with expected values between 0 and 1. 
Figure 7 depicts the scatterplots between each potential 
explanatory variable and the response variable, DPT. The non-
parametric Spearman Correlation Coefficient (rs) is used to determine 
the existence of a monotonic association between the variables, since 
they do not seem to follow a linear relationship. 
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Figure 7 Scatterplot input/output 
 
Table 10 displays the rs per measurement. The results point out 
a negative correlation between CP Admission and DPT since the 
variables have opposite direction. In turn, the correlations of 
DPTM1/DPT and DPTM2/DPT can be considered as moderate. The 
correlations from the third measurement on are stronger.  
The measurements for the first six weeks are analyzed in the 
next section as input variables to determine a model for predicting 
percentage of recovery of the patient with TBI since the CP Admission 
and DPTMm with m=1,…,6 seem to be related to the output variable 
DPT.  
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Table 10 Spearman Correlation Coefficients between the inputs and the output 
variables 
 
CP 
Admission 
DPTM1 DPTM2 DPTM3 DPTM4 DPTM5 DPTM6 
DPT -0.612             
DPT   0.536           
DPT     0.688         
DPT       0.716       
DPT         0.799     
DPT           0.796   
DPT             0.813 
 
Model Building 
Support Vector Regression (SVR) is utilized to determine a good 
relationship between the input and the output variables. SVR is a 
machine learning technique, which lies in predicting the DPT given a 
new input value after observing the behavior of the training set. 
The selection of SVR is based on its two main characteristics: 
generalizability and robustness. The generalizability characteristic 
helps avoid over-fitting because it searches for the simplest model 
through the use of specific margin-limiting data points to define the 
function, which are called Support Vectors (SVs) (Nalbantov, Groenen, 
& Bioch). On the other hand, the robustness characteristic decreases 
the effect of outliers in the model, since SVR works with the absolute 
value of the errors (Nalbantov et al.).  
SVR is approximated through Eq. 5. w determines the 
orientation of the hyperplane in the space and b defines the distance of 
the hyperplane from the origin, both are the parameters of the model. 
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x is the input space, and ø(x) is a function that allows transforming the 
input space into a higher dimensional feature space for mapping. 
 
 fx= w · ø(x) + b Equation 5 
 
This work uses linear and non-linear functions to create a model. 
To obtain a linear function, the input space ø(x) is replaced by Eq. 6, 
where vi are the SVs. 
 
 
Kvi, x= viT ∙ x Equation 6 
 
To estimate a non-linear function, the Radial Basis Function 
(RBF) is often used since it works well for small samples (Zhang, Tang, 
Zhu, & Wang). In addition, the RBF models are less complex than the 
models developed with others kernels since the extra hyperparameter 
required is only one (Hsu, Chang, & Lin, 2003). To obtain a RBF, 
ø(x) is substituted by Eq. 7, where vi are the SVs, and Г is a pre-
defined parameter which is greater than zero. 
 
 Kvi, x=e(-Гvi-x
2
) Equation 7 
 
To estimate the parameters w and b in Eq. 5, the convex 
optimization problem depicted in Eq. 8 must be solved. 
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Minimize         
1
2
 ‖w‖2 + C ∑ (ξ
i
+ ξ
i
*
)li=1   
Subject to      y
i
-(w∙∅(x)+ b)  ≤ ɛ+ ξ
i
    
                        	w∙∅(x)+b - y
i
 ≤ ɛ+ ξ
i
*
   
   ξ
i
, ξ
i
*
  ≥0   
  for i=1,2,…, l 
Equation 8 
 
The objective function in Eq. 8 shows a trade-off between the 
flatness of the solution through the regularization term 
1
2
 ‖w‖2, and the 
amount of training errors through the empirical risk represented by 
C∑ (ξi+	ξi*)li=1 . In turn, the data points that fall inside of the ɛ-
insensitive region are considered with an error equal to 0 (i.e. ξi=0  
and ξi
*
=0), thus, they are not penalized. In the same way, if the error 
is greater than ɛ (i.e. the data point falls outside of the ɛ-insensitive 
region), a penalty C is assigned. The data points that fall in the border 
or outside of the ɛ-insensitive region are SVs which define the function 
(Figure 8). 
Eq. 8 can be transformed into a dual problem after applying the 
Lagrange Multiplier method (LMM). The use of the LMM is due to its 
quadratic objective function and linear constraints. After solving the 
dual problem the parameters w and b for the linear and the RBF 
kernels can be determined.  
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Source: Own creation 
Figure 8 Support Vector Regression (SVR) 
 
The SVR approximation function, thus, can be re-written as 
shown in Eq. 9, where αi
*≥0 and αi≥0 are Lagrange Multipliers, and vi 
are the SVs. 
 
 fx=  αi*- αiKvi, x+b
l
i=1
 Equation 9 
 
The flatness and the training errors of the solution are directly 
associated with the hyperparameters ɛ (ɛ-insensitive loss function) and 
C (cost). They must be specified in advance for the linear and the RBF 
kernels, as well as the hyperparameter Г, which is specific for the RBF 
kernel.  
The hyperparameters C, Г and ɛ are determined using the Grid 
Search Method, which is performed using the function tune() of the 
package e1071 in R (Team, 2008). Grid Search Method performs 
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exhaustive analysis of the possible combinations of the 
hyperparameters values. The selection of the values of the 
hyperparameters, and therefore, the selection of the model(s) is based 
on the Mean Square Error (MSE) after 10-fold cross validation. 
To analyze the effect of different sizes of the ɛ-insensitive region 
over the MSE, three values of the parameter ɛ are preliminarily 
utilized: 1, 0.1, and 0.01. These values are used for both, linear and 
RBF kernels. Once the hyperparameters C and Г are defined, they are 
fixed to tune the hyperparameter ɛ.  
To find the appropriate hyperparameter C for the linear kernel, 
two ranges were analyzed per each input/output combination totaling 
2000 trials: [0.001, 1] increasing by 0.001, and [1, 1000] increasing 
by 1. Two more iterations were performed for the second range to 
obtain a more accurate value. The second iteration has 11 trials that 
were performed using a range of ±0.5 over the best values in the first 
iteration. The third iteration has 11 trials from the best value in the 
second iteration in a range of ±0.05. Table 11 summarizes the ranges 
of iteration for the linear kernel. 
The first iteration for the RBF kernel has the same range for both 
hyperparameters: C and Г: from 1 to 40 increasing by 1, totaling 1600 
trials. The second iteration has a range of ±0.5 from the best value in 
the first iteration. The third iteration has a total of 121 trials in a range 
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of ±0.05 from the best value in the second iteration. Figure 9 shows 
an example of one of the combination with three iterations for the RBF 
kernel. 
 
Table 11 Grid Search method: ranges for the linear kernel 
LINEAR  
Range 
1 
Hyperparameter Iteration 1 
C (0.001,1) 
ɛ 
1 
0.1 
0.01 
Range 
2 
Hyperparameter Iteration1 Iteration2 Iteration3 
C (1,1000) Cost1 ±0.5 Cost2 ±0.05 
ɛ 
1 
0.1 
0.01 
1 
0.1 
0.01 
1 
0.1 
0.01 
Cost 1: Best cost obtained in the iteration 1 
Cost 2: Best cost obtained in the iteration 2 
 
 
  
Source: Own creation 
Figure 9 Example of relationship among Г, C and MSE of a RBF. First iteration 
with 1600 trials (up) second iteration with 121 trials (left) third iteration with 121 
trials (right). 
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A second range is analyzed for the RBF kernel from 0.001 to 1 
increasing by 0.001 for the hyperparameter C, and from 0.1 to 1 
increasing by 0.1 for the hyperparameter Г. To obtain a more accurate 
value of Г two more iterations are performed, where the 
hyperparameter C is fixed according to the value obtained in the first 
iteration, Г ranges ±0.05 over the best value in the first iteration. The 
third iteration is performed over the best value of the second iteration 
in a range of ±0.005. The summary of the ranges used for the RBF 
kernel are shown in Table 12. 
 
Table 12 Grid Search method: ranges for the RBF kernel 
RADIAL 
Range 
1 
Hyperparameter Iteration1 Iteration2 Iteration3 
C (1,40) Cost1±0.5 Cost2±0.05 
ɛ 
1 
0.1 
0.01 
1 
0.1 
0.01 
1 
0.1 
0.01 
Г (1,40) Gamma1±0.05 Gamma2±0.05 
Range 
2 
 
Hyperparameter Iteration1 Iteration2 Iteration3 
C (0.001,1) Best Cost Best Cost 
ɛ 
1 
0.1 
0.01 
1 
0.1 
0.01 
1 
0.1 
0.01 
Г (0.1,1) Gamma1±0.05 Gamma2±0.005 
Cost 1: Best cost obtained in the iteration 1 
Cost 2: Best cost obtained in the iteration 2 
Gamma 1: Best gamma obtained in the iteration 1 
Gamma 2: Best gamma obtained in the iteration 2 
 
The results of the Grid Search Method (Appendix C) show that 
the MSEs are similar when comparing the values for C less than 1 and 
C greater than 1. On the other hand, the iterative process fails to 
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improve the MSE in any of the input/output combinations. Basically, 
the iterations do not find a better value for the parameter C and Г that 
considerably decreases the MSE.  
According to the MSE criterion the best model for the linear 
kernel corresponds to the percentage of recovery measured after the 
4th week of treatment, i.e. the DPTM4 (Table C2). This model 
corresponds to a ɛ-insensitive loss function equal to 1, the number of 
SVs is 6, and the value of the hyperparameter C is equal to 0.94. The 
MSE after 10-fold cross validation is 0.052.  
If the parameter C is fixed at 0.94, and ɛ is tuned in the range 
[0.5, 1] increasing by 0.001, the MSE decreases slightly to 0.051 at ɛ 
equal to 0.99. Since the MSE does not have a significant improvement, 
and the value of C is virtually unchanged, the hyperparameter ɛ is set 
at 1 to find w and b. 
The linear model is obtained by replacing the linear Eq. 6 in Eq. 
5, as shown in Eq. 10.  
 
 fx=	 αi*-	αi viT xj+b
l
i=1
 Equation 10 
 
The parameter w is defined for the linear kernel, as the 
summation of the multiplication between the Lagrange Multipliers and 
their SVs. Table 13 shows the Lagrange Multipliers for the 6 SVs of the 
linear case.   
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Table 13 Patient ID, Lagrange Multipliers, and Support Vectors of the best linear 
model 
Patient ID Lagrange Multiplier Support Vector 
6 0.94 -1.05 
9 0.94 -1.02 
23 0.36 0.46 
37 -0.94 -1.05 
38 -0.94 -1.12 
45 -0.36 -1.05 
 
SVR gives better results standardizing the variables to mean 
zero and to unit variance as this procedure equalize the data variability 
and the ranges and avoids calculation problems related to range 
variability (Bao & Liu, 2006; Hsu et al., 2003). The input variable 
DPTM4 is Z-score scaled according to Eq. 11, where 0.313 is the mean 
of the input variable, and 0.297 is the standard deviation. The SVR 
approximation for the linear kernel with ɛ = 0.1 and C = 0.94 is shown 
in Eq. 12, where 0.638 is w and -0.139 is b. 
 
 DPTM4'=	DPTM4- 0.313
0.297
 Equation 11 
   
 DPTF' = 0.638 * DPTM4'- 0.13 Equation 12 
 
Note that the fitted values obtained using Eq. 12 are scaled due 
to the standardization of the variables before solving the optimization 
problem. In turn, the parameters w and b are also affected by the 
standardization of the variables. Therefore, it is necessary to scale 
back the fitted values calculated through SVR (Eq. 12). The scale back 
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formula for the fitted values is shown in Eq. 13, where 0.036 is the 
mean of DPT variable (observed values) and 0.517 is its standard 
deviation.  
 DPTF = DPTF' * 0.337 + 0.517 Equation 13 
 
The final linear model is obtained by re-writing the Eq. 12 using 
the scale back formula Eq. 13 and replaced the DPTM4’ by Eq. 11. Eq. 
14 illustrates the final linear model and Figure 10 depicts the observed 
and fitted values using the linear model. 
 
 DPTF = 0.724 * DPTM4+ 0.337 Equation 14 
 
 
Black instances: observed values 
Red instances: fitted values 
Source: Own creation 
Figure 10 Linear model with the lower MSE: DPT observed/DPT fitted of each 
patient  
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On the other hand, the values of the RBF parameters (Appendix 
C) point out that ɛ = 0.1 and ɛ = 0.01 have the smaller MSE (0.045). 
In both scenarios the DPTM3 is considered as the best input variable. 
In this case the model that has fewest numbers of SVs has been 
chosen  
The hyperparameter C and Г are fixed to the values 1.25 and 
15.74, respectively and ɛ is tuned in the range [0.05, 0.5] increasing 
by 0.001. For an ɛ equal to 0.483, slight improvement can be obtained 
(0.043 MSE) by cross validation. For simplicity we will continue using 
the value of ɛ = 0.1 for the analysis of the RBF model. 
The equation for the best RBF is obtained by replacing Eq. 7 in 
Eq. 5 as shown in Eq. 15. Eq. 16 shows the RBF model with the lower 
MSE, where 0.450 is the parameter b and 15.74 is the parameter Г.  
 
 fx=  αi*- αie(-Гvi-x
2
)+b
l
i=1
 Equation 15 
   
 DPTf
'=  αi*- αie(-15.74 * ‖vi-DPTM3'‖2)+0.450
l
i=1
 Equation 16 
 
The input variable DPTM3 is also scaled according to Eq. 17, 
where 0.271 is the mean of the input variable and 0.282 is its 
standard deviation.  
 
 DPTM3' = 
DPTM3 - 0.271
0.282
 Equation 17 
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In this case is not possible to calculate the parameter w explicitly 
since the SVs must be handled in the RBF kernel before multiplying 
them by the Lagrange Multipliers αi
* and 	αi. Table 14 shows the 40 
Lagrange Multipliers and the SVs for the RBF model. 
 
Table 14 Lagrange Multipliers and Support Vectors for the best model of RBF 
kernel 
Patient 
ID 
Lagrange 
Multiplier 
Support 
Vector 
Patient 
ID  
Lagrange 
Multiplier 
Support 
Vector 
3 -1.250 -0.853 29 1.250 -0.959 
4 1.250 -0.782 30 -0.695 0.210 
5 -1.250 -0.711 31 0.270 1.166 
6 1.250 -0.959 32 1.250 -0.747 
9 1.250 -0.959 33 -1.250 -0.959 
10 1.250 0.883 34 -1.250 0.812 
11 1.250 0.599 35 1.250 0.210 
12 0.308 2.016 36 -1.250 -0.959 
13 -1.250 1.308 37 -1.250 -0.959 
15 -1.250 -0.888 38 -1.250 -0.959 
16 0.519 1.662 39 0.274 0.706 
17 -1.166 -0.215 40 1.250 1.272 
18 -1.028 -0.286 41 0.652 2.371 
19 0.716 -0.782 43 -1.031 -0.393 
21 -0.604 0.103 44 -0.069 1.449 
23 1.250 -0.003 45 1.250 -0.215 
24 -0.858 0.918 46 -0.294 -0.959 
25 -0.743 -0.959 47 1.250 -0.959 
26 -1.250 -0.959 48 1.250 -0.959 
28 1.250 -0.357 49 -1.250 0.458 
 
Since Eq. 15 gives a fitted value scaled, it must be scaled back 
according to Eq. 17, where 0.524 is the standard deviation and 0.337 
is the mean of the DPT variable. Eq. 15 can be re-written as shown in 
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Eq. 18. The observed and fitted values for the sample are depicted in 
Figure 11.  
 
 DPTF= DPTF 
'  * 0.337 + 0.524 Equation 18 
   
 
DPTF=  
0.337 *[ αi*- αie(-15.74 * vi- (
DPTM3 - 0.271
0.282

2
)
]+0.676
l
i=1
 
Equation 19 
 
 
Black instances: observed values 
Red instances: fitted values 
Source: Own creation 
Figure 11 RBF model with the lower MSE: DPT observed/DPT fitted of each 
patient  
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CHAPTER IV: 
RESULTS AND DISCUSSION 
 
Results 
The analysis developed in the previous chapter indicates that 
after applying the SVR approach, the models based on DPTM4 and 
DPTM3 have the lower MSE after 10-fold cross validation for linear and 
RBF models, respectively.  
Below are some general considerations of both the linear and the 
RBF models. Also there are specific considerations for each model. 
 
General Considerations of the Models 
The RBF model is optimum using as the input variable week 3 
(DPTM3), whereas the linear model uses week 4 (DPTM4). Since it is 
desirable to predict the expected recovery (DPT), as early as possible, 
the RBF model could be more advantageous. 
The RBF model, on the other hand, is a more complicated 
calculation since it requires handling the SVs and the Lagrange 
multipliers each time that a new input data point is considered. The 
linear model is simpler than the RBF model, since the form resembles 
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a simple linear regression. However, both SVR models have the 
disadvantage that the parameters do not have a direct and intuitive 
interpretation. 
Negative input variables or negative output results are possible, 
but unexpected. Figure 12 shows three patients who present negative 
values at different points in their rehabilitation: the squares represent 
a patient who had a negative value after the first week of treatment, 
the circles a patient with a negative value in the middle of the 
rehabilitation, and the diamonds a patient that had a negative value at 
the end.  
 
Source: Own creation 
Figure 12 Examples of trajectories of the patients with negatives values 
 
The negative values may be due to the effect of some factors 
external to the treatment received. These factors can be caused by 
adverse reactions to medication; the genetic, physical, and cognitive 
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characteristics of the patient; or by the evaluator, e.g. error in the 
application of the metrics, an error in recording information in the 
database, or an error in collecting the data.  
 
Considerations for the Linear Model 
According to the linear model, the fitted values DPTF is -0.39 
when DPTM4=-1 and 1.06 when DPTM4=1. Therefore, a potential 
output range is -0.39 ≤ DPTF ≤ 1.06, note however, that the upper 
limit exceeds the allowed value 1. On the other hand, the linear model 
fits better in the interval -0.02 ≤ DPTM4 ≤ 0.94 since this is the input 
range of the dataset. In turn, the range of fitted values according to 
the previous input range is 0.32 ≤ DPT ≤ 1.02, which also exceeds the 
upper limit allowed (Table 15). 
 
Table 15 Output ranges for the linear model 
 Input Range Output Range 
Potential input range -1 ≤ DPTM4 ≤ 1 -0.39 ≤ DPTF ≤ 1.06 
Input range of the sample -0.02 ≤ DPTM4 ≤ 0.94 0.32 ≤ DPT ≤ 1.02 
 
As it has been shown previously, the linear model presents an 
“inconvenience” with the upper limit since the measurement of the 
input and the output variables is a “percentage”, and thus the 
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predicted values should not be more than 1. On the other hand, the 
linear SVR model can predict values in the interval -∞, +∞.  
There are some alternatives to deal with this situation. These 
include rescaling the DPTF to a proper interval (e.g. [-0.39, 1] for the 
potential input range or [0.32, 1] for the input range of the sample) or 
truncate the data at 1, i.e. fitted values over 1 are considered as 1. 
The first option is problematic since modifying the upper value implies 
a change in all the values of the interval as shown Figure 13. The 
second option is considered more appropriate for this situation since 
the values that go beyond the upper limit are close to 1, and there are 
just a few cases. 
 
Circles: Observed values 
Squares: Fitted values 
Diamonds: Fitted values scaled 
Source: Own creation 
Figure 13 Rescale the data in the interval [-0.39, 1] 
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A linear model better fits the premise that the expected result 
after treatment is that the patient improves. However, the linear SVR 
model does not predict if a patient with a lower probability of recovery 
at week 4 maintains the same condition nor if he/she will have a 
significant improvement at discharge. This situation could mean an 
under-fitted linear model (Figure 14). Unfortunately, it is possible to 
confirm or reject this postulate only if there is a validation dataset for 
testing. As mentioned before, since the sample used is small, it was 
not feasible to separate the data into training and test sets and cross 
validation was employed. This will assess repeatability but does not 
fully evaluate systematic error in the model. 
 
Circles instances: Observed values 
Squares instances: Fitted values 
Source: Own creation 
Figure 14 Scatterplot DPTM4 vs. DPT observed and DPT fitted 
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Considerations for the RBF Model 
The fitted value DPTF, according to the RBF model is 0.68 for 
DPTM3=-1, and 0.78 for DPTM3=1. However, the RBF model works 
better for the range of input data points: 0 ≤ DPTM3 ≤ 0.94, since it 
corresponds to the input range of the sample analyzed. The output 
fitted values, DPTF, for this input interval is 0.03 for DPTM3=0 and 
0.95 for DPTM3=0.94 (Table 16). 
 
Table 16 Output ranges for the RBF model 
 Input Range Output Range 
Potential input range -1 ≤ DPTM3 ≤ 1 
DPTF (-1)=0.68 
DPTF (1)=0.78 
Input range of the sample 0 ≤ DPTM3 ≤ 0.94 
DPTF (-1)=0.03 
DPTF (1)=0.95 
 
The results establish that the output interval 0.68 ≤ DPTF ≤ 0.78 
cannot be considered as the wider output range of the RBF model 
since there are other input values (e.g. DPTM3=0) in the range -1 ≤ 
DPTM3 ≤ 1 that estimate lower final percentages of recovery (e.g. 
DPTF (0)= 0.03). In this sense, the fitted values computed using the 
RBF model may not be “as expected” due to the radial curves of the 
model. As shown Figure 15, the RBF model predicts improvement in 
over 90% of patients in whom the percentage of recovery in week 3 is 
close to 30%, while the DPTF is about 60% for a patient close to 40% 
of recovery in week 3. 
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Source: Own creation 
Figure 15 RBF model 
 
The DPTF estimated could point out a possible problem of over-
fitting in the RBF model, which means that the RBF model adjusts the 
instances of the sample fairly well but could not fit properly a new data 
point (Figure 16). Since the sample used is too small to create a 
testing set, it is not possible to confirm or reject this postulate. 
 
Square instances: Observed values 
Circle instances: Fitted values 
Source: Own creation 
Figure 16 Scatterplot DPTM3 vs. DPT observed and DPT fitted 
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Comparison of Delta Transformed and Not-Transformed 
After defining the best input variables to predict DPT using a 
linear and a RBF model, it is analyzed if the transformation of the delta 
generates significant improvement than a delta no transformed in term 
of MSE. Thus, a new linear and RBF models were created considering 
the Delta Pathway Not-transformed (DP) as output variable and the 
Delta Pathway Not-transformed Measurement 4 (DPM4) and Delta 
Pathway Not-transformed Measurement 3 (DPM3) as input variables for 
the linear and RBF model, respectively.  
The parameters ϵ and C for the linear model and the parameters 
ϵ, C and Г for the RBF model are determined using the Grid Search 
method considering the same ranges used for the delta transformed 
(Table 11 and Table 12). The parameters that define the linear model 
with the lower MSE is shown in Table 17, and the parameters that 
define the lower MSE for the RBF model is shown in Table 18. 
 
Table 17 Comparison between linear model using Delta No-Transformed (DP 
and DPM4) and Delta Transformed (DPT and DPTM4)  
 LINEAR 
Delta Transformed 
LINEAR 
Delta No-Transformed 
Input DPTM4 DPM4 
Output DPT DP 
Epsilon 1 0.1 
Cost 0.94 881.45 
Min Observed Value -0.018 102 
Max Observed Value 1 -1 
MSE 0.052 509 
NRMSE 0.22 0.21 
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Table 18 Comparison between RBF model using Delta No-Transformed (DP and 
DPM3) and Delta Transformed (DPT and DPTM3)  
 RBF  
Delta Transformed 
RBF 
Delta No-Transformed 
   
Input DPTM3 DPM3 
Output DPT DP 
Epsilon 0.1 1 
Gamma 15.74 0.1 
Cost 1.25 0.573 
Min Observed Value -0.018 102 
Max Observed Value 1 -1 
MSE 0.045 523 
NRMSE 0.21 0.22 
 
Since the MSE of the Deltas Transformed and Deltas Not 
Transformed have different units, the comparison cannot be done 
directly between the MSEs, it is necessary to normalize them before 
making a conclusion. In this case the Normalized Root Mean Square 
Error (NRMSE) technique was used (Eq. 20). 
According to Table 17 and 18, the values of the NRMSE are the 
same in variables transformed and variables not-transformed. This 
indicates that for this sample the use of a delta transformed does not 
improve the accuracy of the prediction. Again, a larger sample could 
provide more information if the transformation of the variables has a 
significant effect over the prediction. 
 
 NRMSE = 
√MSE
Yobs, max- Yobs, min
 Equation 20 
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Discussion  
Predicting accurate clinical outcomes in patients with TBI is a 
challenge, particularly in patients returning from the OEF or OIF with 
multiple, sever injuries (polytrauma), since the rehabilitation process 
is complex and slow. Although it is true that the data used are not 
sufficient to say that a model is robust, this work has shown that it is 
possible to find patterns in this type of patients, despite the different 
ranges in the rate of the progress of each one.  
Since a metric used to measure outcome requires validation in 
terms of responsiveness, reliability and validity, it could indicate that 
there is an additional “task” related to the CP which seems to have not 
been “quantified” previously. The literature is devoid of studies 
validating the use of CP as a tool to measure outcomes. The CP metric 
was not validated in the work presented above because it requires a 
much larger sample size to reflect the use of the metric by different 
personnel and at different times. It was assumed that the CP is an 
appropriate metric to assess outcomes, as a result of the similarity 
between CP and FIM, where the latter has been widely studied. Thus, 
although face validity can be reasonably accepted, responsiveness and 
reliability of CP must be studied further. 
On the other hand CP has an advantage over FIM, since it is 
measured weekly. A weekly metric provides a larger input set to 
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choose the possible input variables. Assessing data from points other 
than admission (first measurement) allows incorporating the effect 
that the treatment has had for the patient. 
On the other hand, even though a model that uses DPT as 
outcome presents similar NRMSE to a model that uses Delta as output, 
the use of DPT as a measure of the clinical outcome better 
communicates the significance of the patient’s progress to all involved. 
Consequently, interested parties, such as the family, do not need a 
working knowledge of the CP metric. In turn, the clarity and simplicity 
in the information that the families may receive address two of their 
needs: the need to make sense of the experience and the need to 
know. Furthermore, the variable used as “clinical outcome” is based on 
the individual potential recovery, which will help in better determining 
the necessary resources and staff when setting personalized objectives 
for a patient.  
On the other hand, it is possible that the models created using 
SVR are influenced by confounding variables since the data do not 
come from a controlled experiment. Other variables, such as age, 
marital status, damage area of the brain, psychological problems (e.g. 
PTSD), physical and genetic conditions, among others, can also affect 
the recovery of the patient. Ideally these could be controlled in a 
randomized experiment. However, such an experiment is not realistic 
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when it involves people in circumstances where the effect of the 
“natural recovery” is unclear (Paolucci et al., 2000; Roth & Harvey, 
2000). 
The models proposed in this study should be validated using a 
testing set to make a better decision about which model is more 
appropriate and to further explore the possibility of over or under 
fitting the models. This requires a larger sample of patients who 
completed their rehabilitation in the PRCs. The present study suggests 
that recording of CP has to be emphasized in the first, third, fourth and 
last week of rehabilitation since the models ware optimum at based on 
those 4 weeks. 
Lastly, this study is retroactive and it is the first one that uses 
CP as a predictor of clinical outcomes. It sets a precedent for future 
research related to this metric given the advantage of the CP over FIM, 
the assessment of continuous improvement and the accountability of 
the processes that are carried out. 
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CHAPTER V: 
CONLUSIONS AND FUTURE WORK 
 
Conclusions 
The use of the CP as a tool to measure the clinical outcome in 
rehabilitation has positive effects for prediction since the metric is 
weekly. This allows having a wider range of alternatives as potential 
model inputs. In turn, the selection of a measurement other than to 
the admission (first measurement), but at the same time close to this 
first measurement, allows for the inclusion of the progress of the 
patient before predicting the possible clinical outcome. 
The output used to measure the clinical outcome, DPT (Delta 
Pathway Transformed), is the potential recovery achieved by the 
patient, and it is based on the fact that a patient with lower 
functionality makes considerable progress over the rehabilitation time 
as opposed to the patients that arrive to the PRCs with higher 
functionality. However, for the sample analyzed, DPT fails in improving 
the accuracy of the model in comparison with the widely used output 
“delta”. The use of either of them is a good outcome variable since 
they have the same NRMSE. Though, the variable DPT, conceptually, is 
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meaningful and easier to understand which contributes to a better 
communication with the stakeholders, especially the family. A bigger 
sample can address better the advantage of a transformation in terms 
of accuracy of the prediction. 
The input variables analyzed DPTMm are based on the same 
foundations as DPT. The correlation of the first 7 measurements 
studied shows that all of them are related to the output variable, DPT. 
However, the correlation is stronger from measurement 3.  
The machine learning technique, SVR (Support Vector 
Regression) has been used to determine both a linear and a non-linear 
model and has intrinsic properties of robustness and generalizability. 
For the non-linear case, the RBF (Radial Basic Function) kernel was 
used because of the good results in small samples. In turn, the 
parameters ϵ, C, and Г for the linear and RBF cases were defined using 
the Grid Search Method, which is the most widely used method to 
optimize the parameters.  
The linear model has a MSE around 4.5% when DPTM4 is the 
input variable. The RBF model, on the other hand, has a lower MSE 
when the input variable is the measurement done after the 3rd week of 
treatment (DPTM3). More data to validate the models are required. 
The rehabilitation process for individuals with TBI that have been 
exposed to blast injury in OIF and OEF is prolonged and complex. The 
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recovery of the patients is influenced by additional unmeasured factors 
such as: support of the family in the rehabilitation process; genetic, 
physical and psychological conditions; and the severity and location of 
the injury. These factors, although critically important in assessing 
patient rehabilitation, are very difficult to measure and incorporate in a 
predictive model.  
Finally, the necessity of clear information to support decision 
making, communication with the family and preparation for discharge, 
highlights the importance of determining outcomes as early as 
possible. This approach is the first study that uses the weekly metric 
CP in an attempt to predict the clinical outcome of patients with TBI. 
 
Future Work 
Increase the sample data: Additional data should be collected 
from the 5 PRCs over a larger range of years (e.g. 2001 – 2013 These 
data will allow validating the CP metric and the models.  
Validation of the CP metric: CP metric must be validated as a 
tool to measure clinical outcomes. The validation will measure the 
ability of the metric in detecting changes, the ability in quantifying 
motor and cognitive progress, and the consistency of the metric when 
it is used by different evaluators and in repeated measures.  
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Validation of the linear and RBF models: The linear and the RBF 
models should be validated using the CP scores of the new patients 
incorporated. The methodology used in this work could then be applied 
to a larger sample. 
Resources required: once a model is validated, it will assist in 
determining the resources required to achieve the maximum 
improvement of each patient. These resources refer to the amount and 
type of procedures that the facility should emphasize for the efficient 
and effective provision of treatments. 
Create cooperative links with other rehabilitation centers: 
extending the use of CP scores to other centers of rehabilitation 
(private) will help to more fully analyze the methodology used in this 
study in other type of patients and diseases, collecting more data, 
more quickly since the patients in the private sector, with less complex 
injuries/illnesses, typically have more rapid progress. 
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Appendix A: Nomenclature 
 
ADL: Activities of Daily Living  
CP: Clinical Pathways  
CT: Computed Tomography  
DFT: Delta FIM Transformed  
DoD: Department of Defense 
DP: Delta Pathway  
DPMm: Delta Pathway Measurement m 
DPT: Delta CP Transformed  
DPTMm: Delta Pathway Measurement m 
FIM: Functional Independence Measure  
FY: Fiscal Year  
GCS: Glasgow Coma Scle  
GWOT: Global War on Terror  
JAHVAH: James A. Haley Veterans' Hospital  
MRI: Magnetic Resonance Imaging  
MSE: Mean Square Error  
mTBI: mild TBI (mTBI) 
NRMSE: Normalized Root Mean Square Error 
OEF: Operation Enduring Freedom  
OIF: Operation Iraqi Freedom  
OND: Operation New Dawn  
PCS: Post-Concussion Syndrome  
PNS: Polytrauma Network Sites  
PPOC: Polytrauma Point of Contact  
PRC: Polytrauma Rehabilitation Center  
PSC: Polytrauma/TBI System of Care  
PSCT: Polytrauma Support Clinic Teams  
PTE: Post-Traumatic Epilepsy  
PTSD: Post-Traumatic Stress Disorder  
RBF: Radial Basic Function 
SM(s): Service Member(s)  
SV(s): Support Vector (s) 
SVR: Support Vector Regression 
TBI: Traumatic Brain Injury  
TCMm: Total Cognitive Measurement m  
TMMm: Total Motor Measurement m  
VA: Department of Veterans Affairs  
VAH: Veteran Affair Hospital 
  
71 
 
Appendix B: Pathway Components Scale 
 
Table B1 Pathway component “eating” 
Scale Description 
1 Independent. 
2 
Feeds self with extra time safety, or needs assistive device, wears 
dentures, or needs modified food consistency 
3 
Needs supervision for safety or to help cut food, open containers, pour 
liquids, butter bread or apply orthosis 
4 Needs occasional help to scoop food or place utensil in hand 
5 Feeds self about half the time but needs help to complete meals. 
6 Feeds self-less than half the time or less than half the meals.  
7 
Unable to feed self, needs helper to hold utensil, bring food/liquid to 
mouth or needs total assistance with tube feeding 
 
Table B2 Pathway component “grooming” 
Scale  Description 
1 No issues / needs related to grooming, grooming problems or needs 
2 
Grooming requires and assistive device, takes more than reasonable time, 
or there are safety considerations 
3 
Requires no more help than standby assistance, verbal cueing, or coaxing, 
without physical contact, or helper sets up needed items or applies 
orthosis. 
4 
Expends 75% or more the effort and requires no more than touching or 
hands-on assistance. 
5 
Expends 50% to 74% of the effort and requires more help than touching 
assistance. The assistance of only one person is required 
6 
Expends 25% to 49% of the effort. The assistance of only one person is 
required. Is able to direct another person to perform the task. 
7 
Expends less than 25% of the effort. Can require assistance of one or 
more persons or in the clinician's judgment, the subject would be put at 
risk for injury if the task was performed 
 
Table B3 Pathway component “bathing” 
Scale  Description 
1 Complete independence  
2 
Modified independence. Requires adaptive or assistive device, or extra 
time. 
3 Supervision or setup 
4 Minimal contact assistance. Performs 75% or more of tasks 
5 Moderate assistance. Performs 50% to 74% of tasks 
6 Maximal assistance. Performs 25% to 49% of tasks 
7 Total assistance. Performs less than 25% of tasks, or is not bathed 
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Appendix B (continued) 
Table B4 Pathway component “dressing - upper body” 
Scale  Description 
1 Complete independence  
2 
Modified independence. Requires adaptive or assistive device, or extra 
time 
3 Supervision or setup 
4 Minimal contact assistance. Performs 75% or more of tasks 
5 Moderate assistance. Performs 50% to 74% of tasks 
6 Maximal assistance. Performs 25% to 49% of tasks. 
7 Total assistance. Performs less than 25% of tasks, or is not dressed 
 
Table B5 Pathway component “dressing - lower body” 
Scale  Description 
1 Complete independence  
2 
Modified independence. Requires adaptive or assistive device, or extra 
time 
3 Supervision or setup 
4 Minimal contact assistance. Performs 75% or more of tasks 
5 Moderate assistance. Performs 50% to 74% of tasks 
6 Maximal assistance. Performs 25% to 49% of tasks. 
7 Total assistance. Performs less than 25% of tasks, or is not dressed 
 
Table B6 Pathway component “toileting” 
Scale  Description 
1 Complete independence  
2 
Modified independence. Requires equipment or extra time, or there are 
safety considerations.  
3 Supervision or setup 
4 Minimal contact assistance. Performs 75% or more of toileting tasks 
5 Moderate assistance. Performs 50% to 74% of toileting tasks 
6 Maximal assistance. Performs 25% to 49% of toileting tasks. 
7 Total assistance. Performs less than 25% of toileting tasks 
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Appendix B (continued) 
 
Table B7 Pathway component “bladder management” 
 
Scale  Description 
1 
Complete independence. Controls bladder completely and intentionally 
and is never incontinent 
2 
Modified independence. Requires a device or medication for control; 
device is used independently. No accidents. 
3 
Supervision or setup to maintain voiding pattern or external device. Has 
accidents less often than every two weeks. 
4 Minimal contact assistance. Has accidents less often than weekly 
5 Moderate Assistance. Has accidents less often than daily 
6 
Maximal assistance. Wet almost on a daily basis, needs diaper or other 
device. 
7 Total assistance. Wet on a daily basis, needs diaper or other device.  
  
Table B8 Pathway component “bowel management” 
Scale  Description 
1 
Complete Independence. Controls bowel completely and intentionally and 
is never incontinent 
2 
Modified independence. Requires a device or medication for control. 
Device is used independently. No accidents 
3 
Supervision or setup. To maintain bowel pattern or external device. Has 
accidents less often than every two weeks. 
4 Minimal contact assistance. Has accidents less often than weekly. 
5 Moderate assistance. Has accidents less often than daily.  
6 
Maximal assistance. Incontinent almost on a daily basis, needs diaper or 
other device 
7 
Total assistance. Incontinent or a daily basis, needs diaper or other 
device.  
 
Table B9 Pathway component “bed mobility” 
Scale  Description 
1 
Can be left alone to perform the activity safety and within a reasonable 
length of time 
2 Uses equipment or needs extra time 
3 
Cannot be left alone to perform the activity safely. May require set-up, 
cueing or stand-by assist 
4 
Perform 75% or more of the task. May require hands-on or "contact" 
guard 
5 
Performs 50% to 74% of the task. Only one person is required for 
physical assistance. 
6 
Performs 25% to 49% of the task. Only one person is required for 
physical assistance.  
7 
Total assistance. Performs less than 25% of the task. One or more 
persons may be required. 
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Appendix B (continued) 
 
Table B10 Pathway component “locomotion” 
Scale  Description 
1 
Walks 150 feet + (50 meters) without devices. Does not use a wheelchair. 
Performs safety 
2 
Walks 150 feet + (50 meters) but uses a device, needs extra time or 
there are safety considerations 
3 
Requires standby supervision, cueing, or coaxing to walk 150 feet + (50 
meters). Or requires standby supervision, cue, or coax to go a minimum 
of 150 feet (50 meters) in wheelchair.  
4 
Performs most of locomotion effort to go a minimum of 150 feet (50 
meters) 
5 
Performs approximately half of locomotion effort to go a minimum of 15o 
feet (50 meters) 
6 
Provides lees than half of locomotion effort to go a minimum of 50 feet 
(17 meters). Requires assistance to one. 
7 
Makes little effort, or needs assistance of two people, or does not walk or 
wheel a minimum of 50 feet (17 M) 
 
Table B11 Pathway component “transfer” 
Scale  Description 
1 Complete independence 
2 
Requires device, takes more than reasonable time or there are safety 
considerations 
3 Requires supervision (e.g. standing by, cueing, or coaxing) or set-up 
4 Performs 75% or more of transferring tasks 
5 Performs 50% to 74% of transferring tasks 
6 Performs 25% to 49% of transferring tasks 
7 Performs less than 25% of transferring tasks 
 
Table B12 Pathway component “language comprehension” 
Scale  Description 
1 Participation in activities is not limited by spoken language comprehension 
2 Understands complex messages. Rarely requires minimal cueing 
3 
Understands structured conversations. Occasionally requires cueing for 
complex messages. 
4 
Occasionally understands simple directions and conversations about 
routine daily activities without cues. 
5 
Answers simple yes/no questions and follows simple directions with 
moderate cues. 
6 
Follows simple directions and answers simple yes/no questions with 
maxima cues. 
7 
Alert, but does not follow simple direction or responds to yes/no questions 
, even with cues. 
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Appendix B (continued) 
 
Table B13 Pathway component “expression” 
Scale  Description 
1 
Independent participation in activities is no limited by expressive 
language/speech skills 
2 Rarely requires minimal cueing to produce complex sentences 
3 
Communicates successfully in structured conversations. Occasionally 
requires cueing for complex sentences. 
4 
Communicates in simple conversations in routine daily activities with 
familiar communication patterns. 
5 
Produces words and phrases that are appropriate and meaningful in 
context with moderate cues 
6 
Occasionally produces automatic or imitative words/phrases, rarely 
meaningful 
7 
The individual attempts to speak, but verbalizations are not meaningful at 
any time 
 
Table B14 Pathway component “attention” 
Scale  Description 
1 
Independent functioning but may occasionally include the use if 
compensatory strategies 
2 
Maintains attention within complex activities and attends simultaneously 
to multiple demands with rare minimal cues 
3 
Maintains attention within simple living activities with occasional minimal 
cues within distracting environments 
4 
Maintains attention during simple living task with consistent minimal 
cueing 
5 
Maintain attention to complete simple living tasks of short duration with 
consistent moderate cueing. 
6 
Can attend with consistent maximal stimulation, but not long enough to 
complete even simple living tasks 
7 
Attention is nonfunctional. The individual is generally unresponsive to 
most stimuli.  
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Appendix B (continued) 
 
Table B15 Pathway component “memory” 
Scale  Description 
1 
Independent in recalling or using strategies for complex information and 
planning future events in all activities 
2 
Recalls or uses strategies for complex information and planning events 
most of the time or with rare minimal cues. 
3 
Consistently requires minimal cues to recall or use strategies for 
complex/novel information 
4 
Requires minimal cues to use aids for simple information. Requires 
maximal cues to use aids for complex information 
5 
Occasionally requires maximum cues to recall or use external aids for 
simple routine and personal information 
6 
Consistently requires maximal verbal cues or uses external aids to recall 
personal information 
7 The individual is unable to recall any information regardless of cueing 
 
Table B16 Pathway component “social language” 
Scale  Description 
1 
Consistently and independently able to modify behaviors in response to 
feedback from the environment 
2 
Socially appropriate in most settings or situations with occasional minimal 
cues. Responds to subtle feedback 
3 
Socially appropriate in unfamiliar settings and with unfamiliar partners 
with consistent minimal cueing 
4 
Adheres to simple rules of social communication is structured settings, but 
needs maximum cues in unfamiliar situations 
5 
Rarely uses common and simple social communication without cues even 
in structured settings  
6 
Pragmatics are functional in familiar and structured settings with familiar 
people and maximum cueing  
7 
Cannot initiate appropriate responses and is unaware of the need and 
feedback of the communication partner 
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Appendix B (continued) 
 
Table B17 Pathway component “problem solving” 
Scale  Description 
1 
Initiates and completes complex tasks. Acknowledges deficits and need to 
use compensation as appropriate 
2 
Initiates and completes complex tasks with occasional prompting. Repair 
errors with minimal cues. 
3 
Initiates complex tasks with prompting and consistently completes certain 
multi-step tasks. Responds impulsively 
4 
Initiates routine tasks; requires repeated prompts to complete multi-step 
tasks. Recognize errors when pointed out. 
5 
Requires prompt to initiate tasks, but completes them with no prompting. 
May trouble with perseveration or switching. 
6 
Requires prompt to initiate simple tasks, but may be able to complete 
some of them without  constant prompting 
7 
Initiates only with physical prompting; requires repeated prompts. Is 
automatic, reflexive, or perseverative. 
 
Table B18 Pathway component “safety” 
Scale  Description 
1 Can be left alone indefinitely and/or can pursue all normal activities alone 
2 
Can be left alone for an entire day but may need supervision with new or 
complex activities 
3 
Needs daily supervision and/or some help in the community. Can be left 
alone for short periods 
4 
Independent only within the hospital. Could not be left alone, due to 
safety considerations. 
5 
May go to therapies, but must to be supervised in all other areas. Client 
could not be left alone. 
6 
Needs supervision in all settings. Off the ward only when accompanied by 
staff or trained family 
7 Requires close supervision (poseyed or one on one supervision) 
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Appendix C: SVR Parameters 
 
The results of Grid Search for linear kernel and for RBF kernel 
include the SVs, the best hyperparameter C, the best hyperparameter 
Г (for RBF kernel), and the MSE after a 10-fold cross validation for the 
three iterations of the combination DPT/M1 and DPT/DPTMm 
(m=1,…,6). 
 
Table C1 Linear kernel-range 1: C (1,1000) 
INPUT M0 DPTM1 DPTM2 DPTM3 DPTM4 DPTM5 DPTM6 
OUTPUT DPT DPT DPT DPT DPT DPT DPT 
Epsilon 1 1 1 1 1 1 1 
SVs 14 20 9 12 6 6 9 
Cost 307 1 1 630 6 4 5 
MSE 0.081 0.099 0.067 0.069 0.052 0.055 0.057 
SVs 16 0.5 9 12 6 5 9 
Cost 306.6 20 0.9 630 5.5 4.5 4.5 
MSE 0.085 0.099 0.065 0.069 0.052 0.054 0.062 
SVs 16 20 9 11 6 5 9 
Cost 306.6 0.45 0.86 630.04 5.55 4.55 4.45 
MSE 0.082 0.099 0.067 0.069 0.052 0.054 0.058 
Epsilon 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
SVs 47 47 43 44 42 42 40 
Cost 7 203 866 3 968 2 1 
MSE 0.085 0.110 0.075 0.069 0.066 0.062 0.068 
SVs 47 47 43 44 42 42 38 
Cost 6.7 202.5 866.3 2.7 967.5 1.7 0.5 
MSE 0.093 0.103 0.075 0.070 0.067 0.068 0.061 
SVs 47 47 43 44 42 42 38 
Cost 6.75 202.55 866.31 2.68 967.48 1.75 0.45 
MSE 0.102 0.106 0.074 0.066 0.068 0.069 0.077 
Epsilon  0.01 0.01 0.01 0.01 0.01 0.01 0.01 
SVs 49 49 49 48 46 45 43 
Cost 449 1 4 250 2 1 1 
MSE 0.088 0.109 0.072 0.070 0.066 0.065 0.071 
SVs 49 49 49 48 46 45 43 
Cost 993.5 1.4 4.4 249.8 2.5 1 0.6 
MSE 0.103 0.106 0.071 0.073 0.065 0.068 0.062 
SVs 49 49 49 48 46 45 43 
Cost 993.53 1.38 4.43 249.83 2.51 0.45 0.57 
MSE 0.102 0.106 0.073 0.068 0.070 0.074 0.078 
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Appendix C (continued) 
 
Table C2 Linear kernel-range 2: C (0.001, 1) 
INPUT M0 DPTM1 DPTM2 DPTM3 DPTM4 DPTM5 DPTM6 
OUTPUT DPT DPT DPT DPT DPT DPT DPT 
Epsilon 1 1 1 1 1 1 1 
SVs 14 20 10 12 6 6 8 
Cost 0.829 0.247 0.319 0.264 0.94 0.746 0.782 
MSE 0.083 0.097 0.066 0.062 0.052 0.055 0.058 
Epsilon  0.1 0.1 0.1 0.1 0.1 0.1 0.1 
SVs 49 49 49 47 47 44 43 
Cost 0.064 0.624 0.658 0.093 0.096 0.124 0.058 
MSE 0.083 0.109 0.072 0.068 0.057 0.059 0.065 
Epsilon 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
SVs 47 47 43 42 41 39 38 
Cost 0.117 0.081 0.545 0.103 0.158 0.14 0.078 
MSE 0.083 0.109 0.074 0.070 0.057 0.057 0.065 
 
Table C3 RBF kernel-range 1: C (1.40), Г (1,40) 
INPUT M0 DPTM1 DPTM2 DPTM3 DPTM4 DPTM5 DPTM6 
OUTPUT DPT DPT DPT DPT DPT DPT DPT 
Epsilon  1 1 1 1 1 1 1 
SVs 13 16 9 8 9 7 8 
Cost 27 21 30 3 9 4 4 
Gamma  5 2 1 1 1 1 1 
MSE 0.075 0.075 0.063 0.062 0.059 0.063 0.062 
SVs 11 16 10 9 8 8 7 
Cost 27.3 20.8 29.7 3.2 8.7 4.2 4.5 
Gamma 5.5 1.6 0.5 0.5 0.5 0.7 0.5 
MSE 0.074 0.076 0.058 0.058 0.057 0.062 0.066 
SVs 11 16 10 9 8 7 7 
Cost 27.26 20.8 29.67 3.17 8.67 4.23 4.55 
Gamma  5.45 1.64 0.46 0.45 0.45 0.65 0.53 
MSE 0.080 0.073 0.062 0.057 0.057 0.060 0.063 
Epsilon  0.1 0.1 0.1 0.1 0.1 0.1 0.1 
SVs 45 46 45 40 38 38 35 
Cost 2 1 1 1 4 40 1 
Gamma 1 3 1 16 0.1 1 3 
MSE 0.082 0.077 0.055 0.047 0.049 0.060 0.044 
SVs 45 44 46 40 38 37 33 
Cost 2.5 0.6 0.6 1.2 4.3 39.8 1.2 
Gamma 0.5 2.8 1.3 15.7 1 0.9 3.2 
MSE 0.083 0.079 0.061 0.046 0.049 0.056 0.048 
SVs 45 45 45 40 39 37 33 
Cost 2.55 0.65 0.65 1.25 4.35 39.77 1.15 
Gamma 0.55 2.85 1.34 15.74 0.99 0.91 3.24 
MSE 0.082 0.072 0.059 0.045 0.047 0.062 0.049 
Epsilon  0.01 0.01 0.01 0.01 0.01 0.01 0.01 
SVs 49 48 49 49 46 43 42 
Cost 2 2 1 1 1 1 1 
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Appendix C (continued) 
 
Table C3 (Continued)  RBF kernel-range 1: C (1.40), Г (1,40) 
Gamma 1 1 1 19 1 1 3 
MSE 0.085 0.075 0.055 0.047 0.050 0.061 0.046 
SVs 48 49 47 48 47 45 43 
Cost 2.4 0.5 0.9 0.6 1.5 1.5 0.5 
Gamma 0.7 1.9 0.6 19.5 0.6 0.5 2.5 
MSE 0.086 0.076 0.059 0.046 0.051 0.059 0.052 
SVs 49 49 48 48 47 45 43 
Cost 2.39 0.55 0.95 0.65 1.55 1.46 0.55 
Gamma 0.65 1.95 0.61 19.54 0.65 0.45 2.55 
MSE 0.083 0.072 0.055 0.045 0.046 0.061 0.055 
 
Table C 4 RBF kernel-range 2: C (0.001,1), Г (0.1,1) 
INPUT M0 DPTM1 DPTM2 DPTM3 DPTM4 DPTM5 DPTM6 
OUTPUT DPT DPT DPT DPT DPT DPT DPT 
Epsilon  1 1 1 1 1 1 1 
SVs 13 20 10 11 6 6 6 
Cost 0.857 1 1 0.833 1 1 0.914 
Gamma  0.3 1 0.9 0.3 0.3 0.2 0.2 
MSE 0.082 0.083 0.063 0.061 0.058 0.061 0.062 
SVs 12 20 10 11 6 6 6 
Cost 0.857 1 1 0.833 1 1 0.914 
Gamma 0.25 1.05 0.9 0.35 0.25 0.22 0.2 
MSE 0.088 0.082 0.061 0.060 0.056 0.062 0.063 
SVs 12 20 10 11 6 6 6 
Cost 0.857 1 1 0.833 1 1 0.914 
Gamma  0.253 1.055 0.85 0.345 0.255 0.217 0.205 
MSE 0.086 0.080 0.064 0.061 0.057 0.060 0.061 
Epsilon  0.1 0.1 0.1 0.1 0.1 0.1 0.1 
SVs 44 44 44 44 40 39 39 
Cost 0.489 0.765 0.668 0.464 0.93 0.274 0.547 
Gamma 0.5 1 0.9 1 0.6 0.5 1 
MSE 0.075 0.080 0.055 0.046 0.048 0.053 0.049 
SVs 44 43 44 44 40 40 39 
Cost 0.489 0.765 0.668 0.464 0.93 0.274 0.547 
Gamma 0.53 1.04 0.95 0.99 0.6 0.55 1.05 
MSE 0.080 0.080 0.062 0.053 0.052 0.057 0.050 
SVs 44 43 44 44 44 40 39 
Cost 0.489 0.765 0.668 0.464 0.93 0.274 0.547 
Gamma 0.535 1.045 0.954 0.995 0.605 0.55 1.055 
MSE 0.088 0.077 0.060 0.052 0.050 0.060 0.057 
Epsilon  0.01 0.01 0.01 0.01 0.01 0.01 0.01 
SVs 48 47 48 49 48 45 43 
Cost 0.35 0.59 0.656 0.382 0.235 0.228 0.322 
Gamma 0.9 1 0.9 0.9 1 1 0.9 
MSE 0.073 0.078 0.053 0.045 0.047 0.052 0.049 
SVs 48 47 48 49 47 45 43 
81 
 
Appendix C (continued) 
 
Table C4 (Continued)  RBF kernel-range 2: C (0.001,1), Г (0.1,1) 
 
Cost 0.35 0.59 0.656 0.382 0.235 0.228 0.322 
Gamma 0.94 1.05 0.88 0.85 1.05 0.95 0.85 
MSE 0.078 0.078 0.059 0.053 0.053 0.054 0.052 
SVs 48 48 48 49 47 45 43 
Cost 0.35 0.59 0.656 0.382 0.235 0.228 0.322 
Gamma 0.935 1.055 0.876 0.845 1.055 0.955 0.855 
MSE 0.082 0.078 0.056 0.048 0.052 0.059 0.061 
 
 
